ALMR insider trading

NasdaqGS Healthcare

Alamar Biosciences, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades
120
Last 90 days
120
Buys / sells
2% / 0%
Market cap
$1.46B

About Alamar Biosciences, Inc.

Alamar Biosciences, Inc., a proteomics company, develops a proteomic liquid biopsy platform and sells instruments, consumables, and services to early detection of diseases. The company develops NULISA technology, a proteomics platform that detects and quantifies protein biomarkers. It offers ARGO high throughput (HT) System, a fully automated precision proteomics platform, performs ultra-high sensitivity and multiplexed analysis to support biomarker analysis across the continuum of discovery, translational research and ultimately, and diagnostics. The company's offering is utilized in research areas including immunology, neurology, and oncology. It serves global research and academic institutions, biopharmaceutical companies, contract research organizations, and service labs. The company operates in the United States, rest of Europe, Middle East and Africa, Germany, Asia Pacific, and internationally. The company was incorporated in 2018 and is based in Fremont, California.

Company website: alamarbio.com

ALMR insider activity at a glance

FilingIQ has scored 120 insider transactions for ALMR since Apr 16, 2026. The most recent filing in our index is dated Apr 20, 2026.

Across the full history, 2 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on ALMR insider trades is 66.5/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

Latest ALMR Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

Top insiders trading ALMR

Frequently asked

How many insider trades does FilingIQ track for ALMR?
FilingIQ tracks 120 Form 4 insider transactions for ALMR (Alamar Biosciences, Inc.), covering filings from Apr 16, 2026 onwards. 120 of those were filed in the last 90 days.
Are ALMR insiders net buyers or net sellers?
Across the full Form 4 history for ALMR, 2 transactions (2%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does ALMR insider data come from?
Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is ALMR in?
Alamar Biosciences, Inc. (ALMR) is classified in the Healthcare sector, specifically Medical Devices, with a current market capitalisation of $1.46B.

Methodology & sources

Every ALMR insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.